Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
(Adnkronos) – GAITHERSBURG, Md., Oct. 3, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Novavax COVID-19 Vaccine, Adjuvanted
